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Ionotropic glutamate receptor (iGluR) subunits con-
tain a large N-terminal domain (NTD) that precedes
the agonist-binding domain (ABD) and participates
in subunit oligomerization. In NMDA receptors
(NMDARs), the NTDs of NR2A and NR2B subunits
also form binding sites for the endogenous inhibitor
Zn2+ ion. Although these allosteric sites have been
characterized in detail, the molecular mechanisms
by which the NTDs communicate with the rest of
the receptor to promote its inhibition remain un-
known. Here, we identify the ABD dimer interface
as a major structural determinant that permits
coupling between the NTDs and the channel gate.
The strength of this interface also controls proton
inhibition, another form of allosteric modulation of
NMDARs. Conformational rearrangements at the
ABD dimer interface thus appear to be a key mecha-
nism conserved in all iGluR subfamilies, but have
evolved to fulfill different functions: fast desensitiza-
tion at AMPA and kainate receptors, allosteric inhibi-
tion at NMDARs.
INTRODUCTION
In the vertebrate CNS, the amino acid glutamate mediates fast
excitatory neurotransmission by acting on iGluRs, which are
integral membrane proteins containing glutamate-gated cat-
ion-permeable channels. iGluRs are subdivided into three sub-
families: AMPA, kainate, and NMDA receptors (Dingledine
et al., 1999). While AMPA and kainate receptors form a class of
receptors endowed with fast kinetics and profound desensitiza-
tion, NMDARs are distinguished by their slow kinetics and limited
desensitization. Another distinctive feature of NMDARs is that
their activity is tightly controlled by many endogenous sub-
stances. Among them, extracellular H+ and Zn2+ ions, which
act as allosteric inhibitors, are particularly interesting because
they are likely to provide tonic inhibition of NMDARs under phys-
iological conditions, suggesting an important role of these mod-
ulators in the control of neuronal excitability (Westbrook and
Mayer, 1987; Traynelis and Cull-Candy, 1991; Paoletti et al.,
1997; Vogt et al., 2000). In addition, during intense neuronal80 Neuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc.activity, increased NMDAR inhibition following rises in synaptic
H+ and Zn2+ concentrations (Traynelis and Chesler, 2001; Smart
et al., 2004) may provide a way to limit NMDAR overactivation
and therefore prevent neuronal injury. However, the structural
basis by which these modulators exert their effects on NMDARs
remains to be elucidated.
iGluRs have a characteristic modular architecture, with each
subunit containing four discrete domains (Mayer, 2006; Paoletti
and Neyton, 2007): in the extracellular region, a tandem of large
globular bilobate domains, the N-terminal domain (NTD) involved
in subunit oligomerization followed by the agonist-binding do-
main (ABD) directly connected to the transmembrane part;
a channel-forming domain comprising three transmembrane
segments (TM1, -2, and -3) plus a re-entrant pore-loop (P); and
a cytoplasmic C-terminal domain involved in receptor trafficking
at the synapse. Although iGluRs are tetrameric complexes, re-
cent crystallographic and functional studies of the ABDs of
AMPA and kainate receptors have revealed that these receptors
operate as dimers of dimers. The bilobate ABDs of two adjacent
subunits formdimers through back-to-back appositionof lobes1,
burying a large surface area involving extensive contacts be-
tween the two partner subunits (see Figure 1). These studies
have also established that the ABD dimer interface is a central
structural element in the receptor gating process and have led
to a comprehensive mechanistic model for receptor activation
and desensitization. Agonist binding in the interlobe cleft of
each ABD induces cleft closure, a movement that increases
the separation between lobes 2 of the two adjacent subunits be-
cause their lobes 1 are ‘‘glued’’ together. According to the model,
this separation, in turn, exerts some tension on the linkers con-
necting the ABDs to the transmembrane segments leading to
opening of the ion channel. In the model, desensitization occurs
when the dimer undergoes a conformational rearrangement that
involves the disruption of the lobe 1 dimer interface. This uncou-
ples agonist-induced cleft closure from channel gate opening, al-
lowing the ion channel to close while individual ABDs remain in
their agonist-bound conformation (Sun et al., 2002; Jin et al.,
2003; Horning and Mayer, 2004; Armstrong et al., 2006; Weston
et al., 2006; Mayer, 2006). The recently solved structure of the
NMDAR NR1/NR2A ABD heterodimer, which shows a strong
structural conservation of the ABD dimer arrangement with that
of non-NMDA receptors, indicates that the mechanism coupling
ligand binding to channel gating is likely to be similar in NMDA
receptors (Furukawa et al., 2005). However, in NMDARs, fast
AMPAR-like desensitization does not occur, and it is unknown
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Mechanism of NMDA Receptor Allosteric InhibitionFigure 1. The Heterodimeric Organization of ABDs in NR1/NR2A NMDA Receptors
(A) Left: Schematic representation of the domain organization of NMDA receptors. CTD, intracellular C-terminal domain; TMD, transmembrane domain that com-
prises the ion-channel pore; ABD, agonist binding domain that binds glycine (or D-serine) in NR1 and glutamate in NR2 subunits; NTD, N-terminal domain that
forms in NR2A a modulatory domain binding with high affinity the allosteric inhibitor zinc. An intact receptor is believed to form a tetrameric complex assembled as
a dimer of dimers. Right: Side and top views of the NR1/NR2A ABD heterodimer crystal structure (Furukawa et al., 2005). Helices aD and aJ, which form the main
interaction surfaces at the interface between the two partner subunits, are labeled. Note that interactions between the two subunits involve almost exclusively
residues from lobes 1.
(B) Amino acid sequence alignment of the ABD segments that form the dimer interface contacts in NMDA, AMPA, and kainate receptors. On top, secondary
structure assignment for NR1 and NR2A (a helices in orange and b sheet in blue) is shown. Amino acids directly contacting the agonist molecule (glutamate,
or glycine for NR1 and NR3 subunits) are marked with an asterisk, while conserved residues are indicated by gray boxes. Boxed residues indicate positions
that were mutated in the present study.whether the ABD dimer interface rearranges during gating and
to what extent dimer stability influences channel activity.
In NMDARs, the NTDs are not only important for receptor as-
sembly (Meddows et al., 2001) but also form binding sites for al-
losteric (noncompetitive) ligands that modulate receptor activity.
The NTDs of both NR2A and NR2B subunits bind the negative
modulator Zn2+ with high (nM) and low (mM) affinity, respectively
(Choi and Lipton, 1999; Paoletti et al., 2000; Low et al., 2000;
Rachline et al., 2005); in addition, the NR2B NTD binds the
drug ifenprodil (Perin-Dureau et al., 2002). Results from site-di-
rected mutagenesis experiments coupled to molecular modeling
suggest that Zn2+ and ifenprodil bind the NTD interlobe central
cleft and promote domain closure through a ‘‘clamshell-like’’
mechanism resembling the mechanism of action of glutamate
at neighboring ABDs. A major challenge is now to understand
how the binding of a ligand at the very N-terminal regions of
the receptor leads to ion channel closure. In the case of NR1/
NR2A receptors, Low et al. (2000) have proposed that zinc inhi-
bition proceeds through an enhancement of proton sensitivity.
More recently, Mayer (2006) proposed a model in which NTDclosure destabilizes theABD dimer interface.Thismodel,however,
has not been experimentally tested, and therefore the mechanis-
tic coupling between the NTDs and the gating machinery is still
an open question. An intriguing side observation that attracted
our attention is that NTD ligands, in parallel to their inhibitory ef-
fects on receptor activity, paradoxically increase receptor affinity
for glutamate (Kew et al., 1996; Paoletti et al., 1997; Erreger and
Traynelis, 2005). That is, NTD ligands promote entry into a state
in which the receptor is inactive but has an increased affinity for
the agonist, a feature that is a hallmark of desensitized states.
Given the central importance of the dimer interface between ad-
jacent ABDs in AMPA and kainate receptor desensitization, we
investigated the role of the ABD interface in the allosteric modu-
lation of NMDARs by NTD ligands. By introducing mutations at
specific locations in the NR1/NR2A ABD dimer, we show that,
in NR1/NR2A receptors, the ABD heterodimer interface has a piv-
otal role in the transduction pathway linking the NTDs to the
channel gate, and we propose a mechanistic scheme for alloste-
ric regulation of NMDAR activity by the N-terminal modulatory
domains.Neuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc. 81
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Mechanism of NMDA Receptor Allosteric InhibitionFigure 2. Disrupting the Hydrophobic Cores of the ABD Dimer Interface Generates Receptors with Enhanced Zinc Sensitivity
(A) Magnified views of the two hydrophobic clusters that form major sites of subunit-subunit contact in the NR1/NR2A ABD dimer interface. Homologous residues
NR1-L777 (site A) and NR2A-L780 (site B), each on helix J, are at the center of a hydrophobic cluster, contacting through Van der Waals interactions the other
residues at each site displayed in the yellow stick representation. Site A and site B are related by the pseudo-two-fold molecular symmetry of the dimer assembly.
(B) Comparison of current traces obtained from oocytes expressing either wild-type (wt) NR1/NR2A receptors, mutated NR1-L777A/NR2Awt receptors, or
NR1wt/NR2A-L780A receptors. Zinc was applied at increasing concentrations (5, 50, and 500 nM) during an application of 100 mM glutamate and 100 mM glycine.
(C) Zinc inhibition concentration-response curves for NR1-L777A/NR2Awt (Inhibmax = 99%, IC50 = 1.1 nM, nH = 0.94, [n = 5]) and NR1wt/NR2A-L780A (Inhibmax =
97%, IC50 = 1.2 nM, nH = 0.97, [n = 5]) mutant receptors compared with wt receptor (dashed line; Inhibmax = 81%, IC50 = 10.5 nM, nH = 0.91, [n = 5]). Note that in wt
receptors, zinc inhibition is partial while in the mutant receptors it is almost total.
Error bars represent the standard deviation.RESULTS
Disruption of the Hydrophobic Contacts at the ABD
Dimer Interface Increases Zinc Sensitivity
The crystal structure of the isolated NR1/NR2A ABD heterodimer
shows that both subunits are arranged in a ‘‘back-to-back’’ fash-
ion that is similar to the arrangement of subunits in the nonde-
sensitized state of the AMPA GluR2 ABD homodimer (Furukawa
et al., 2005; Figure 1). In particular, the NR1/NR2A ABD interface
comprises numerous contacts made by residues found at (or in
the vicinity of) helices aJ and aD of both subunits, resulting in two
subsites of dimerization: site A, formed by helix J of NR1 and he-
lix D of NR2A; and site B, related to site A by a pseudo-2-fold axis
of symmetry, formed by the helix D of NR1 and helix J of NR2A.
Both sites contain a cluster of highly conserved hydrophobic res-
idues making numerous intersubunit Van der Waals contacts
that are expected to be important in dimer stabilization. We iden-
tified NR1-L777 and the homologous residue NR2A-L780 as res-
idues likely to be essential for subunit dimerization because both
leucines are buried at the core of the hydrophobic cluster with
their side chain methyl groups involved in extensive hydrophobic82 Neuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc.contacts with the neighboring hydrophobic residues including
NR2A-I514 and NR2A-S519 for NR1-L777, and NR1-A524 and
NR1-I519 for NR2A-L780 (Figure 2A). In addition, these two
leucines are homologous to residue GluR2-L751 (Figure 1B),
mutation of which strongly promotes desensitization in GluR2
receptors (Horning and Mayer, 2004).
To explore the roles of NR1-L777 and NR2A-L780 in NMDAR
zinc inhibition, we mutated each of these two leucine residues
separately in alanine, whose shorter lateral chain should strongly
disrupt the hydrophobic interface cluster. Compared to wild-
type (wt) NR1/NR2A receptors, both NR1-L777A/NR2Awt and
NR1wt/NR2A-L780A receptors display greatly enhanced zinc
sensitivity (Figures 2B and 2C). At 5 nM zinc, the lowest zinc con-
centration tested during initial mutation screening, currents were
already strongly reduced (Figure 2B). Whereas at wt NR1/NR2A
receptors, zinc inhibits agonist-induced currents with an IC50
around 10 nM, in the mutated receptors, zinc IC50 was de-
creased by 10-fold (1.1 and 1.2 nM for NR1-L777A/NR2Awt
and NR1wt/NR2A-L780A receptors, respectively; Figure 2C
and Table 1). Another striking modification concerns the maximal
level of zinc inhibition. Whereas, as previously reported, at wt
Neuron
Mechanism of NMDA Receptor Allosteric InhibitionTable 1. Effects of ABD Dimer Interface Mutations on Zn2+ and H+ Inhibitions of NR1/NR2A Receptors
Mutant
Zn2+ Inhibition H+ Inhibition
IC50 (nM) Max. Inhib. (%) nH # Cells pH IC50 nH # Cells
Wild-type 10.5 ± 0.8 81 ± 1 0.91 (5) 6.95 ± 0.05 1.69 (14)
NR1 mutant
I519A 8.9 ± 2.1 84 ± 1** 0.90 (4) 6.95 ± 0.01 1.72 (4)
I519D 2.5 ± 0.4** 97 ± 1** 0.98 (4) a
I519F 8.1 ± 0.1 82 ± 2 0.94 (3) 6.96 ± 0.02 1.60 (3)
I519V 11.7 ± 0.3 77 ± 1 0.84 (3) 6.95 ± 0.02 1.76 (4)
A524D 3.5 ± 0.2** 90 ± 1** 0.95 (7) 6.86 ± 0.02** 1.68 (7)
A524E 2.8 ± 0.1** 95 ± 1** 1.00 (7) 7.01 ± 0.02** 1.36 (5)
A524K 1.5 ± 0.1** 94 ± 1** 0.81 (4) 7.82 ± 0.04** 1.01 (4)
K531A 16.4 ± 0.5** 81 ± 1 0.95 (4) 7.00 ± 0.01** 1.51 (4)
L774A 7.9 ± 0.7* 84 ± 1* 0.90 (7) 6.96 ± 0.02 1.52 (3)
L777A 1.1 ± 0.1** 99 ± 1** 0.94 (7) 9.13 ± 0.05** 0.83 (4-7)
L777C 1.7 ± 0.1** 97 ± 1** 0.84 (7) 7.77 ± 0.05** 0.91 (3)
L777F 0.9 ± 0.1** 96 ± 1** 0.85 (3) 9.18 ± 0.12** 0.54 (4)
L777S 0.9 ± 0.1** 98 ± 2** 0.82 (3) 9.57 ± 0.07** 0.60 (3)
K778A 15.9 ± 0.5* 79 ± 1* 0.89 (4) 6.90 ± 0.01 1.69 (4)
E781A 2.4 ± 0.1** 92 ± 1** 1.10 (9) 7.20 ± 0.06** 1.22 (8)
E781D 7.4 ± 0.3** 87 ± 1** 0.90 (7) 7.14 ± 0.03** 1.62 (4)
E781Q 1.3 ± 0.1** 97 ± 1** 1.00 (8) 8.18 ± 0.05** 0.85 (4)
NR2A mutant
I514A 8.9 ± 0.4 81 ± 1 0.83 (4) 6.97 ± 0.02 1.60 (4)
I514D 16.9 ± 0.2** 87 ± 1** 0.93 (4) N.D.#
V526A 8.4 ± 0.2** 86 ± 1** 0.98 (4) 7.02 ± 0.03** 1.64 (9)
V526K 2.0 ± 0.2** 94 ± 1** 0.83 (10) 7.63 ± 0.04** 1.47 (8)
L777A 2.0 ± 0.1** 91 ± 1** 0.90 (2) 7.19 ± 0.04 * 1.26 (3)
L780A 1.2 ± 0.1** 97 ± 2** 0.97 (6) 9.16 ± 0.10** 0.81 (4-8)
L780C 1.2 ± 0.2** 95 ± 1** 0.85 (6) 8.16 ± 0.05** 0.77 (5)
L780S 1.1 ± 0.2** 96 ± 1** 0.77 (3) 8.88 ± 0.01** 0.59 (3)
L780F N.D. 9.08 ± 0.03** 0.97 (4)
Q781A 12.0 ± 0.9 81 ± 1 0.90 (4) 6.94 ± 0.02 1.67 (3)
NR1 mut. / NR2A mut.
I519A / I514A 8.4 ± 0.5 88 ± 1** 0.91 (4) 7.07 ± 0.03** 1.46 (4)
N521Y / E516Y 10.5 ± 0.4 82 ± 1 1.00 (4) N.D.
E522Q / G784E 15.7 ± 0.8* 71 ± 1** 0.85 (4) 6.82 ± 0.01** 1.95 (5)
A524E / V526K-D776N 1.6 ± 0.1** 97 ± 2** 0.91 (4) N.D.
S773N / S519E 11.3 ± 1.3 77 ± 2 0.99 (3) 6.95 ± 0.02 1.58 (2)
L774A / L777A 1.5 ± 0.1** 93 ± 1** 0.98 (4) 8.04 ± 0.06** 0.72 (3)
a, NR1-I519D/NR2Awt receptors displayed a bell-shaped pH dose-response curve (see Results); N.D., not determined; N.D.#, not determined be-
cause of a strong decrease in glutamate affinity (see Experimental Procedures and Figure S5); *p < 0.05 ; **p < 0.01 compared with wild-type with
Student’s t test modified for unequal variances.NR1/NR2A receptors, saturating the high-affinity zinc binding
site results in partial inhibition (maximal inhibition of 60%–80%;
Paoletti et al., 1997; Choi and Lipton, 1999; Low et al., 2000),
at NR1-L777A/NR2Awt and NR1wt/NR2A-L780A receptors,
residual currents in saturating zinc concentrations were dramat-
ically diminished (maximal inhibition of 99% and 97%, respec-
tively; Figure 2C and Table 1). To make sure that the observed
inhibition was driven by zinc binding to the NR2A NTD and notto other potential sites of lower affinity located outside the NTD
(see Rachline et al., 2005), we checked that high-affinity zinc in-
hibition was absent in receptors combining the NR1-L777A mu-
tation with the NR2A-H128S mutation, a mutation that selectively
abolishes zinc binding to the NR2A NTD (Fayyazuddin et al.,
2000; Low et al., 2000; Paoletti et al., 2000). Indeed, 100 nM
zinc, a concentration that induces an almost complete inhibition
of NR1-L777A/NR2Awt receptors, barely affected the doublyNeuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc. 83
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Mechanism of NMDA Receptor Allosteric Inhibitionmutated NR1-L777A/NR2A-H128S receptors (relative current
93% ± 3% [n = 3]).
To gain further insight into the importance of leucines NR1-
L777 and NR2A-L780 in zinc inhibition of NMDARs, we intro-
duced additional mutations at these positions. As expected
from the introduction of polar residues in a hydrophobic cluster,
substitutions by a serine or a cysteine induced a leftward shift in
zinc sensitivity, similar to that observed with the alanine substitu-
tions, with both an increase in zinc apparent affinity (IC50) and
‘‘efficacy’’ (maximal level of inhibition) (Table 1). Interestingly, in-
troducing a phenylalanine, a bulky hydrophobic residue, also
strongly increased zinc sensitivity (Table 1). Of note, currents car-
ried by NR1wt/NR2A-L780F were so small (<40 nA, due to strong
proton inhibition at pH 7.3; see below) that full zinc concentra-
tion-response curves could not be reliably obtained, although it
was clear that at these receptors zinc was very potent (>50% in-
hibition at 5 nM). Thus, the series of NR1-L777 and NR2A-L780
mutations reveal that perturbing the hydrophobic packing be-
tween the two adjacent ABDs, either by side chain truncation
or change in hydrophobicity (A, C, and S mutations) or through
a likely steric clash (F mutation), markedly increases zinc sensitiv-
ity of NR1/NR2A receptors. These results also indicate that the
two pseudosymmetrical dimerization sites A and B contribute
to a comparable extent to dimer stability, an observation that is
not surprising given the strong sequence homology between
the two protomers in regions constituting the dimer interface.
We next mutated the residues that, in the crystal structure,
partner with leucines NR1-L777 and NR2A-L780 through inter-
subunit contacts. For each leucine, three interacting residues
were identified: NR2A-I514, NR2A-E516, and NR2A-S519 for
NR1-L777 and the homologous residues NR1-I519, NR1-N521,
and NR1-A524 for NR2A-L780 (Figure 2A). Each of these resi-
dues contributes to the dimer interface stability by making an in-
terdomain Van der Waals contact with the distal methyl group of
the adjacent leucine. The influence of the interactions involving
NR2A-E516 and NR1-N521 is difficult to evaluate by mutagene-
sis because these residues contact the corresponding leucine
through their backbone Ca. A similar situation applies to
NR2A-S519 with the involvement of its Cb methylene group
that would only be eliminated with a substitution by glycine. Gly-
cine substitutions, however, are known to disrupt secondary
structures (O’Neil and DeGrado, 1990) and were therefore
avoided. Substituting isoleucine NR1-I519 either by shorter ali-
phatic residues (valine or alanine) or by a large aromatic residue
(phenylalanine) produced very modest effects on zinc sensitivity
(Table 1). Similarly, receptors containing an alanine mutation at
the homologous position in NR2A (NR2A-I514A) displayed
unchanged zinc sensitivity compared to wt receptors (despite
strong effects on agonist sensitivity; Table 1 and see Experimen-
tal Procedures). That valine can substitute for the isoleucine is
not unexpected given that NR1-I519 contacts NR2A-L780
through its Cb branch methyl group, an interaction that could
be preserved in the valine mutant. In contrast, the results ob-
tained with the alanine mutants are surprising because the one
methyl side chain of the alanine is expected to be too short to
form favorable Van der Waals contacts with the key leucines.
Moreover, the homologous mutation GluR2-I481A has a strong
effect on desensitization of AMPA receptors indicative of a84 Neuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc.much weakened dimer interface (Horning and Mayer, 2004).
However, because GluR2 ABDs form homodimers with a 2-
fold symmetric dimerization, each individual mutation is present
twice at the dimer interface, while at heteromeric NMDARs, there
is only one copy of the NR1 or NR2A mutation per heterodimer.
Thus, to match more closely the AMPA receptor situation, we co-
injected NR1-I519A with NR2A-I514A and found that doubly mu-
tated receptors displayed significantly enhanced maximal level
of zinc inhibition compared to singly mutated receptors in agree-
ment with a significant decrease in stability of dimer contacts
(Table 1). Introducing a charged aspartate at these positions
also resulted in markedly enhanced zinc sensitivity, most partic-
ularly in the case of the NR1-I519D mutation, as expected for mu-
tations that strongly disrupt the hydrophobic cluster (Table 1).
Similarly, introducing charged residues at position NR1-A524
(D, E, or K mutation) induced marked increase in zinc sensitivity
(Table 1). Taken together, these results indicate that isoleucines
NR2A-I514 and NR1-I519 as well as alanine NR1-A524 (and
potentially NR2A-S519) are likely to contribute to dimer stability,
although some structural flexibility at the isoleucine positions can
be supported without apparent destabilization of the interface.
The role of the hydrophobic interactions at the dimer interface
in setting zinc sensitivity of NR1/NR2A receptors was further in-
vestigated by mutating additional residues of sites A and B in the
vicinity of NR1-L777 and NR2A-L780. Residue NR1-L774 (site A)
and the homologous residue NR2A-L777 (site B) on helices aJ
form the exterior side of the hydrophobic cluster and contact
the methylene groups of residues from the adjacent subunit
NR2A-E516 and NR2A-S519 (site A), and NR1-N521 and NR1-
A524 (site B) (Figure 2A). When NR1-L774 and NR2A-L777
were individually mutated to alanine, zinc sensitivity increased.
In addition, when NR1-L774A was coinjected with NR2A-
L777A, the corresponding doubly mutated receptors displayed
enhanced zinc sensitivity compared to the singly mutated recep-
tors (Table 1), reinforcing the importance of the ABD intermolecu-
lar Van der Waals contacts in the control of zinc sensitivity. The
shifts in sensitivity, however, were clearly not as marked as with
NR1-L777 or NR2A-L780 mutated receptors. This is consistent
with the fact that NR1-L774 and NR2A-L777 have their side chain
partly solvent accessible and thus are expected to contribute sig-
nificantly less than the other two leucines to dimer stability. Finally,
we tested mutations at NR2A-V526. This residue, part of the site B
hydrophobic cluster, does not make direct contacts with the ad-
jacent NR1 subunit but instead forms an intrasubunit contact with
the key leucine 780 of NR2A (Figure 2A). This latter interaction,
however, is expected to be important for the ABD dimer assembly
because of its likely involvement in the positioning of NR2A-L780.
Consistent with this hypothesis, the alanine truncation mutant
NR2A-V526A led to a small, but significant, increase in zinc
sensitivity, while introduction of a less conservative mutation,
NR2A-V526K, strongly increased zinc sensitivity (Table 1).
Disruption of Hydrogen Bonds at the ABD
Dimer Interface Increases Zinc Sensitivity
Inspection of the NR1/NR2A ABD crystal structure indicates that,
beside hydrophobic contacts, hydrogen bonds also participate
to the stabilization of the ABD dimer interface. This is the case
of residue NR1-E781 at the apex of helix J in site A. NR1-E781
Neuron
Mechanism of NMDA Receptor Allosteric InhibitionFigure 3. Disruption of a Dimer Interface
Hydrogen Bond Network Increases Zinc
Sensitivity
(A) Located at the base of helix J, site A residue
NR1-E781 contributes to the ABD dimer formation
by making two contacts with the adjacent NR2A
subunit: a hydrogen bond with the Na of NR2A-
E516, and an ‘‘indirect’’ hydrogen bond with the
Na of NR2A-E517 via a water molecule (shown
as a red ball).
(B) Zinc inhibition concentration-response
curve for NR1-E781Q/NR2Awt mutant receptors
(Inhibmax = 97%, IC50 = 1.4 nM, nH = 1.01, [n = 3])
compared with wild-type receptors (dashed line;
Inhibmax = 81%, IC50 = 10.5 nM, nH = 0.91, [n = 5]).
Error bars represent the standard deviation.is in a fully extended conformation and makes a bidentate contact
with the base of helix D of the adjacent NR2A subunit very much
like GluR2-E755 in AMPA receptors (Horning and Mayer, 2004).
Residue NR1-E781 makes a direct hydrogen bond with the back-
bone amide nitrogen of NR2A-E516 and a hydrogen bond with
the backbone amide nitrogen of NR2A-E517 via a water molecule
(Figure 3A). The favorable electrostatic interaction between the
negatively charged glutamate and the dipole of the aD helix of
NR2A may also contribute to the dimer interface cohesion. To re-
move these interactions, NR1-E781 was first substituted into
alanine. This resulted in a marked enhancement of zinc sensitivity
with an effect on both zinc IC50 and the maximal level of zinc
inhibition (Zn IC50 of 2.4 nM and maximal inhibition of 92% [n =
9], Table 1). When the glutamate side chain was replaced by a
more conservative aspartate, a shorter negatively charged resi-
due that should weaken both hydrogen bond network and
charge-dipole interaction, zinc sensitivity was increased, but to
a lesser extent (Table 1). Surprisingly, replacing NR1-E781 by a
glutamine, a neutral residue of similar length that should permit
formation of one hydrogen bond with the neighboring D helix
but not the charge-dipole interaction, strongly increased zinc
sensitivity (Zn IC50 of 1.3 nM and maximal inhibition of 97% [n =
8], Figure 3B). This result suggests that the charge-dipole interac-
tion between NR1-E781 and the NR2A aD helix may contribute to
the overall dimer stability. The fact, however, that the Q mutation
has a ‘‘stronger’’ phenotype than the A mutation is difficult to ex-
plain, assuming that the sole effect of the mutation is to weaken
dimer stability and likely reflects additional effects of the Q muta-
tion on other conformational state(s) of the dimer (possibly
through stabilization of a ‘‘desensitized’’ state; see Armstrong
et al., 2006). In conclusion, the hydrogen bond network at the
ABD dimer interface appears to be an important structural
determinant involved in the control of the zinc sensitivity of
NR1/NR2A receptors, most likely by contributing to the stability
of the ABD dimer interface.
Receptors with Cysteine Crosslinked ABDs
Display Redox-State-Dependent Zinc Sensitivity
A prediction based on the preceding results showing that dis-
rupting the intersubunit ABD dimer contacts enhances zinc sen-sitivity is that strengthening dimer stability should also affect zinc
sensitivity. We first tried to increase dimer stability by introducing
either (1) polar residues to mimic the intersubunit salt links pres-
ent in AMPA and kainate ABDs (Horning and Mayer, 2004; Priel
et al., 2006; Plested and Mayer, 2007), (2) tyrosines to mimic the
nondesensitizing GluR2-L483Y receptor situation (Sun et al.,
2002; Furukawa et al., 2005), or (3) mutations to consolidate
the hydrogen bond network between the two partner subunits.
Disappointingly, introducing polar residues or tyrosines pro-
duced either no significant change in zinc sensitivity (NR1-
S773N/NR2A-S519E, NR1-N521Y/NR2A-E516Y) or increased
zinc sensitivity (NR1-A524E/NR2A-V526K-D776N) (Table 1). In
contrast, introducing H bond acceptor groups at position
NR2A-G784 (homologous to NR1-E781) did result in a small,
but significant, decrease in zinc sensitivity (Table 1 and
Figure S1 available online), suggesting that enhanced dimer
stability may render zinc inhibition less potent.
To test the influence of dimer stabilization on zinc sensitivity
more directly, we used an approach based on engineered di-
sulfide bridges. In their study of the NR1/NR2A ABD structure,
Furukawa et al. (2005) showed that it is possible, in full-length
receptors, to crosslink adjacent NR1 and N2A subunits by
introducing two pairs of cysteines at appropriate positions in
the ABD NR1/NR2A heterodimer interface (NR1-N521C-
L777C and NR2A-E516C-L780C, hereafter named NR1-CC
and NR2A-CC, respectively; see Figure 4A). By performing
western blot experiments on whole oocyte extracts, we first
verified that in our hands, and only under nonreducing condi-
tions, such doubly-cysteine mutated NR1 and NR2A subunits
do form heterodimers in an intact receptor (Figure S2). We
then assessed zinc sensitivity of NR1-CC/NR2A-CC receptors
under different redox conditions. In control conditions (i.e.,
before any redox treatments), NR1-CC/NR2A-CC receptors ex-
hibited a maximal zinc inhibition significantly lower than that
observed on NR1wt/NR2Awt receptors (64% versus 81%; Fig-
ures 4B and 4C) as would be expected if a significant propor-
tion of surface NMDA receptors has a reduced zinc sensitivity
because of restrained conformational mobility of covalently
attached ABDs. We obtained further evidence that this is likely
to be the case by treating the oocytes with DTNB, an oxidizingNeuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc. 85
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Mechanism of NMDA Receptor Allosteric InhibitionFigure 4. Redox-Controlled Switch from Low to High Zinc Sensitivity in Receptors Containing Disulfide Bond Crosslinked ABDs
(A) Top view of the NR1/NR2A ABD dimer highlighting the four cysteines introduced at the dimer interface to form intersubunit disulphide bonds (sulfurs are shown
in yellow; Furukawa et al., 2005).
(B) Inhibition by increasing zinc concentrations (5, 50, and 500 nM) of currents carried by NR1-CC/NR2A-CC receptors expressed in a single oocyte under control
conditions and treated sequentially with DTNB (0.5 mM, 5 min), DTE (5 mM, 15 min), DTNB (second round, same concentration, 45 min), and DTE (second round,
same concentration, 15 min).
(C) Zinc inhibition concentration-response curves for NR1-CC/NR2A-CC receptors in control condition (Inhibmax = 64%, IC50 = 6.0 nM, nH = 0.58), after DTNB
treatment (Inhibmax = 37%, IC50 = 3.7 nM, nH = 0.37), and after a subsequent DTE treatment (Inhibmax = 100%, IC50 = 2.0 nM, nH = 0.63). Each point is the
mean value from 5 to 12 cells.
(D) Bar graph showing the residual current at 500 nM zinc (Ires) in control conditions, after DTNB treatment, and after a subsequent DTE treatment, for wt NR1/
NR2A receptors (Ires = 21 ± 0.7% [n = 4]; 25 ± 0.9% [n = 4]; 26 ± 1.4% [n = 4]), NR1-CC/NR2Awt receptors (Ires = 9 ± 1% [n = 6]; 8 ± 1% [n = 6]; 12 ± 1% [n = 5]),
NR1wt/NR2A-CC receptors (Ires = 7 ± 0.4% [n = 4]; 11 ± 2% [n = 4]; 6 ± 0.8% [n = 4]), and NR1-CC/NR2A-CC receptors (Ires = 40 ± 2.4% [n = 12]; 67 ± 3.6%
[n = 11]; 3.6 ± 0.9% [n = 9]). For these latter receptors, a second round of consecutive DTE and DTNB treatments was performed (Ires = 61% ± 0.8% [n = 4];
2.7% ± 0.6% [n = 4], respectively) revealing the reversibility of the redox-induced effects on zinc sensitivity.
Error bars represent the standard deviation.agent that promotes disulfide bond formation. As shown in Fig-
ures 4B and 4C, DTNB treatment strongly reduced the sensitiv-
ity to zinc, as judged by the much lowered maximal level of
inhibition (37%). The fact that zinc sensitivity of DTNB-treated
receptors was not completely abolished may be due either to
a limited access of DTNB to the dimer interface resulting in
a mixed population of receptors with reduced and intact cross-
links or to insufficient time of treatment. Another possibility
could be that even in the crosslinked receptors, some move-
ments at the ABD interface are still possible following zinc bind-
ing to the NTD. Whatever the explanation, we predicted that
breaking the engineered disulfide bonds should restore zinc
sensitivity. Consistent with this idea, DTE treatment (5 mM,
15 min) dramatically increased zinc sensitivity (100% maximal
inhibition; Figures 4B and 4C). The sensitivity of DTE-treated
R1-CC/2A-CC receptors to zinc was in fact similar to that of
receptors harboring a single cysteine mutation at the corre-86 Neuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc.sponding aJ helix leucine positions (R1-L777C/2Awt or R1wt/
2A-L780C receptors; see Table 1), as expected if most of the
disulfide bonds have been cleaved by the DTE treatment.
To verify that the observed effects resulted from a selective mod-
ification of the two disulfide bonds introduced at the subunit
interface, we performed similar redox treatments on oocytes
expressing either wt NR1/NR2A receptors or receptors contain-
ing only one set of double cysteine mutations, which do not
give rise to disulphide-linked NR1/NR2A heterodimers (R1-CC/
2Awt and R1wt/2A-CC receptors; Figure S2). As shown in
Figure 4D, none of the redox treatments affected the maximal
level of zinc inhibition of these receptors. Finally, we also found
that it was possible to reversibly switch NR1-CC/NR2A-CC re-
ceptors from a low- to a high-zinc sensitivity state by sequential
applications of DTNB and DTE (Figures 4B and 4D). These results
reveal that crosslinking ABD protomers leads to receptors with
greatly diminished zinc sensitivity and support a model in which
Neuron
Mechanism of NMDA Receptor Allosteric InhibitionFigure 5. Disrupting the Hydrophobic Cores of the ABD Dimer Interface Generates Receptors with Greatly Enhanced Proton Sensitivity
(A) Recordings showing the potentiating effects induced by alkalinization of the external solution on currents carried by wt NR1/NR2A receptors or mutated
NR1-L777A/NR2Awt, NR1wt/NR2A-L780A, and NR1wt/NR2A-L780F receptors. During an application of glutamate and glycine (100 mM each), pH was switched
transiently from pH 7.3 to the indicated value.
(B) Proton inhibition concentration-response curves of NR1-L777A/NR2Awt (pHIC50 = 9.13, nH = 0.83, [n = 4–7]), NR1wt/NR2A-L780A (pHIC50 = 9.16, nH = 0.81,
[n = 4–8]), and NR1wt/NR2A-L780F receptors (pHIC50 = 9.08, nH = 0.97, [n = 4]). For comparison, the proton sensitivity of wt NR1/NR2A receptors is also shown
(dashed line; pHIC50 = 6.92, nH = 1.69, [n = 4]).
Error bars represent the standard deviation.conformational rearrangements of the agonist binding cores are
required to couple zinc binding to the NTD to subsequent channel
closure.
Disruption of the Heterodimer Interface
between ABDs Increases Proton Sensitivity
A distinctive property of the high-affinity zinc inhibition of NR1/
NR2A receptors is that it saturates at a maximal level of 60%–
80% (Paoletti et al., 1997; Choi and Lipton, 1999; Low et al.,
2000). Based on the observation that the extent of maximal
zinc inhibition depends on extracellular pH (inhibition by a satu-
rating zinc concentration increases as proton concentration
increases), it has been proposed that zinc exerts its inhibitory
action on NR1/NR2A receptors through an enhancement of tonic
proton inhibition (Choi and Lipton, 1999; Low et al., 2000). Ac-
cording to this model, the presence of protons is required for
zinc inhibition to occur. The residual current observed at saturat-
ing zinc concentrations and at physiological pH reflects the fact
that saturating the high-affinity zinc binding site does not lead to
saturation of the inhibitory proton binding site at pH 7.3. Given
the strong effects of the ABD dimer interface mutations on zinc
sensitivity, and in particular on the maximal level of zinc inhibi-
tion, we decided to examine the pH sensitivity of our mutant
receptors. We found that mutation of the central leucines of
the ABD interface hydrophobic cores, which greatly enhanced
maximal zinc inhibition (see Figure 2), dramatically increased
proton sensitivity. Thus, as illustrated in Figure 5A, switching
the agonist solution from pH 7.3 to 8.3, which results in a modest1.15-fold increase of wt currents, induced a 4- and 2.6-fold in-
crease of currents carried by NR1-L777A/NR2Awt and NR1wt/
NR2A-L780A receptors, respectively. Currents from mutant re-
ceptors were still profoundly inhibited by H+ at pH 8.3 because
further potentiation could be induced by increasing pH to 9.3
(Figure 5A). Using the series of mutations that we had produced
at these positions, we found that the potentiation was largest for
NR1/NR2A-L780F receptors, with a remarkable 30-fold increase
in current amplitude when jumping from pH 7.3 to 9.3 (Figure 5A).
Performing full concentration-response curves revealed that pH
sensitivity of these mutant receptors was shifted by more than
two orders of magnitude in comparison to wt receptors (pH of
IC50 of 9.13 [n = 4–7] for NR1-L777A/NR2Awt receptors, 9.16
[n = 4–8] for NR1wt/NR2A-L780A receptors and 9.08 [n = 4] for
NR1/NR2A-L780F receptors, versus 6.92 [n = 14] for wt receptor;
Figure 5B).
To obtain a more complete view of the relationship between
zinc and proton sensitivities at NR1/NR2A receptors, we mea-
sured pH sensitivity of many dimer interface mutants covering
a large spectrum of zinc sensitivity (Table 1). Mutant receptors
that displayed enhanced zinc sensitivity also displayed
enhanced pH sensitivity. Two mutant receptors deviated from
this general trend: NR1-I519D/NR2Awt, which showed unusual
biphasic pH sensitivity (with a potentiating and an inhibitory com-
ponent; data not shown), and NR1-A524E/NR2Awt (and to
a lesser extent NR1-A524D/NR2Awt), which showed very little
shift in pH sensitivity despite a marked increase in zinc sensitiv-
ity. We believe that, for these mutants, the ‘‘abnormal’’ pHNeuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc. 87
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ing highly perturbed pKas of the introduced carboxylic groups
(probably because of the clustering of multiple charged residues
in a relatively low polar environment; see Fersht, 1999). Notwith-
standing these latter mutants, we found that the maximal level of
zinc inhibition and proton sensitivity were strongly correlated
(Figure 6). This result agrees well with a model in which NTD-con-
trolled zinc inhibition results from an enhancement of proton
inhibition and indicates that common mechanisms are likely to
operate during zinc and proton inhibition.
We gained additional evidence for a functional interaction be-
tween the ABD dimer interface and the NTDs by measuring pH
sensitivity of receptors combining a NR1 ABD interface mutation
(NR1-E781A) with a NTD-deleted NR2A subunit (NR2A-delNTD;
see Rachline et al., 2005). Although the interface mutation or the
NTD deletion separately caused a modest enhancement of pro-
ton sensitivity (pH of IC50 of 7.3 and 7.2, respectively; Table 1 and
Figure S3), the combination of both modifications resulted in
a strong synergistic increase in proton sensitivity (pH of IC50 of
9.1; Figure S3).
Increased Accessibility of the ABD Dimer
Interface upon Zinc Inhibition
Mutations expected to weaken (or strengthen) ABD dimer stabil-
ity selectively enhance (or decrease) zinc and proton sensitivities
Figure 6. Strong Correlation between pH and Zinc Sensitivities at
NR1/NR2A Receptors
The change in free-energy between the zinc-bound active and inactive states
(DDGZn; an index of the maximal level of zinc inhibition; see Experimental
Procedures) is plotted versus the change in free-energy between the proton-
bound and unbound states (DDGpH; an index of the pH sensitivity; see Exper-
imental Procedures) for wt and 22 interface mutant receptors. Coordinates of
wt NR1/NR2A receptors are (0,0) (open circle). The line represents a linear
regression fit of the data points. The R value of the fit is 0.85. Numbers refer
to the following mutant receptors: 1 = NR1wt/NR2A-I514A; 2 = NR1-I519F/
NR2Awt; 3 = NR1-I519A/NR2Awt; 4 = NR1-L774A/NR2Awt; 5 = NR1-
A524D/NR2Awt; 6 = NR1wt/NR2A-V526A; 7 = NR1-I519A/NR2A-I514A;
8 = NR1-E781D/NR2Awt; 9 = NR1wt/NR2A-L777A; 10 = NR1-E781A/NR2Awt;
11 = NR1-A524E/NR2Awt; 12 = NR1wt/NR2A-V526K; 13 = NR1-A524K/
NR2Awt; 14 = NR1-L774A/NR2A-L777A; 15 = NR1-L777C/NR2Awt; 16 =
NR1wt/NR2A-L780C; 17 = NR1-E781Q/NR2Awt; 18 = NR1wt/NR2A-
L780S;19 = NR1-L777F/NR2Awt; 20 = NR1wt/NR2A-L780A; 21 = NR1-
L777A/NR2Awt; 22 = NR1-L777S/NR2Awt. Data from NR1-I519D/NR2Awt
receptors were excluded from this plot because H+ IC50 could not be accu-
rately measured for these receptors (see Results).88 Neuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc.of NR1/NR2A receptors. This observation strongly suggests that
disruption of the ABD dimer interface, with one protomer moving
away from the other, constitutes a central conformational rear-
rangement occurring during zinc and proton inhibitions, very
much like the movement occurring during AMPA and kainate
receptor desensitization (Armstrong et al., 2006; Weston et al.,
2006; Priel et al., 2006). To probe for this putative conformational
change, we introduced a cysteine residue at the ABD dimer inter-
face and compared the rate of modification of the mutant recep-
tors by the thiol modifying agent sodium (2-sulfonatoethyl)-
methane thiosulfonate (MTSES) with and without zinc. We
hypothesized that attachment of the bulky (2-sulfonatoethyl)-
methane moiety at the ABD interface of the mutated receptors
would increase their sensitivity to zinc and pH, thereby decreas-
ing current sizes. According to a model in which the ABD inter-
face becomes more accessible upon zinc inhibition, the rate of
MTSES modification should be faster in zinc than without. We
chose to introduce the cysteine substitution at position
2A-V526 because of the following criteria: first, this residue, as
judged by the NR1/NR2A ABD dimer crystal structure (Furukawa
et al., 2005), is poorly accessible to the bulk solvent in the ‘‘rest-
ing’’ state of the ABD dimer; second, its mutation to cysteine has
only a very minor effect on zinc sensitivity (Zn IC50 = 10.9 nM and
maximal inhibition of 81%, [n = 3]) such that residual currents in
saturating zinc concentrations are of large enough amplitude to
be accurately measured; third, its replacement by a large
charged residue such as a lysine induced a marked increase in
zinc sensitivity (see Table 1) presumably through disruption of
the dimer interface; fourth, in GluR2 AMPA receptors, the homol-
ogous residue (K493) becomes more exposed to the solvent dur-
ing receptor desensitization (Armstrong et al., 2006).
We observed that the reduction of currents carried by NR1wt/
NR2A-V526C receptors induced by MTSES application was
both faster and of greater amplitude in the presence of zinc (ap-
plied at 500 nM, a saturating concentration) than in its absence
(Figures 7A and 7B). The enhanced magnitude of inhibition
(61% ± 4% [n = 4] inhibition in zinc versus 39% ± 4% [n = 5] in
DTPA) is expected if, in both situations, the decrease in currents
induced by MTSES reflects a similar enhancement of proton
inhibition but starting from receptors under higher tonic proton
inhibition in the zinc conditions (see Low et al., 2000). From a ki-
netic point of view, in both cases, application of MTSES was best
described by a two-component time course. Because the fast
component, but not the slow one, was also observed during
treatment of NR1wt/NR2Awt receptors with MTSES (most likely
due to modification of an endogenous cysteine; data not shown),
we concentrated our analysis on the slow component. On aver-
age, this latter component was 1.9-fold faster in the presence of
zinc than in its absence (Figures 7C and 7D). Thus, the thiol moi-
ety of the interface residue 2A-V526C becomes more accessible
upon NTD-driven zinc inhibition.
DISCUSSION
Using the X-ray crystal structure of the NR1/NR2A agonist-bind-
ing domain dimer (Furukawa et al., 2005), we created a series of
mutants specifically designed to affect the stability of the ABD di-
mer interface. Characterization of these mutants revealed that
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mits functional coupling between the NTDs and the pore region.
Our data also reveal that the ABD dimer interface controls proton
sensitivity. Our results establish that intersubunit contacts be-
tween the ligand binding cores of NR1 and NR2A subunits un-
dergo significant conformational rearrangements during zinc
and proton inhibitions. There are striking similarities between
the effects of our mutants on zinc (and proton) modulation and
the previously described effects of homologous ABD dimer inter-
face mutants on AMPA and kainate receptor desensitization.
Whereas in AMPA and kainate receptors, destabilization of the
Figure 7. MTSES Modification Rate of NR1wt/NR2A-V526C Recep-
tors Is Increased by Zinc
(A) Recording showing the inhibitory effect of 2 mM MTSES on currents carried
by NR1wt/NR2A-V526C receptors. NMDAR currents were induced by 100 mM
glutamate and 100 mM glycine in the absence of zinc (no added zinc plus 10 mM
DTPA).
(B) Same protocol as in (A) (but different cell) except that 500 nM free zinc was
present throughout the experiment.
(C) Comparison of the inhibition kinetics of MTSES in the presence and ab-
sence of extracellular zinc. Current traces from cells shown in (A) and (B)
were normalized and fitted with a biexponential function (dashed lines). The
values of tfast and tslow and their relative weight were 1.4 s (41%) and 35.4 s
(59%) in the absence of zinc (plus DTPA) and 1.3 s (44%) and 11.9 s (56%)
in zinc, respectively. Note that the fast component is likely to reflect MTSES
modification of an endogenous cysteine and not of 2A-V526C because a sim-
ilar fast component of inhibition is also seen on wild-type NR1/NR2A receptors
(while the slow component is not).
(D) Mean time constants of the slow component of MTSES inhibition recorded
in the absence of zinc (no added zinc plus DTPA) or in its presence and mea-
sured as shown in (C). The values of tslow are 28.5 ± 4.9 s (Zn2+, n = 5) and
15.0 ± 2.1 s (+Zn2+, n = 4) (***p < 0.005, Student’s t test).
Error bars represent the standard deviation.interface increases the speed and extent of desensitization
(Sun et al., 2002; Horning and Mayer, 2004; Weston et al.,
2006; Priel et al., 2006; Armstrong et al., 2006; Plested and
Mayer, 2007), we show here that in NMDA NR1/NR2A receptors,
weakening the intersubunit ABD contacts selectively enhances
sensitivity to allosteric inhibitors. Accordingly, we propose
a model for the negative allosteric modulation of NR1/NR2A re-
ceptors centered on the idea that zinc- or proton-inhibited NR1/
NR2A receptors ‘‘resemble’’ AMPA (or kainate) desensitized
receptors (Figure 8; see also Mayer, 2006). In this model, zinc
inhibition proceeds through a sequence of molecular events in-
volving three distinct ‘‘modules’’ of the receptor: the N-terminal
domain (the locus of zinc binding), the agonist-binding domain,
and ultimately the transmembrane region. First, zinc binds the
central cleft of NR2A NTDs (shown following agonist binding in
Figure 8 as state 1) and promotes domain closure by stabilizing
a closed-cleft conformation (Paoletti et al., 2000; Figure 8, state 2).
Second, closure of the NTDs exerts tension on the linker con-
necting the NTDs to the ABDs, destabilizing the ABD dimer as-
sembly and enhancing proton site affinity. Third, pulling apart
of the ABD protomers together with proton binding relieve strain
on the linkers connected to the transmembrane segments, al-
lowing the channel to close, even though the agonists remain
bound to the receptors.
Our model explains why mutations that weaken ABD dimer
stability increase zinc inhibition, whereas crosslinking the two
ABD protomers through disulfide bridges has an opposite effect.
This model accounts for the strong correlation between pH and
zinc modulations (Low et al., 2000 and Figure 6) because, in the
inhibition transduction cascade, proton binding takes place
downstream of zinc-induced closure of the NTDs. This model
also accounts for the increased glutamate affinity induced by
zinc inhibition at the NTD (Paoletti et al., 1997; Erreger and Tray-
nelis, 2005), because separation of the agonist-bound ABDs re-
lieves the strain exerted by the linkers from the transmembrane
segments, thus stabilizing the closed conformation of the
ABDs. Finally, this model highlights the key importance of dimer
interfaces in glutamate receptor-channel activation and modula-
tion. During iGluR activation, agonist-induced closure of the
ABDs pulls open the channel gate because the ABDs are
attached together through their lobes 1 while lobes 2 are able
to move (Mayer, 2006). We suggest that during NMDA receptor
modulation the zinc-induced closure of the NTDs can be trans-
duced into ABD dimer separation because the NTDs are similarly
attached one to the other through their first lobes (Figure 8; see
Madry et al., 2007). Supporting this hypothesis, AMPA receptor
NTDs are known to dimerize (Kuusinen et al., 1999; Ayalon et al.,
2005), and crystal structures from structurally related domains
found in metabotropic glutamate receptors consistently show
that the dimer interface is generated exclusively by lobe 1 con-
tacts (Jingami et al., 2003).
Although our model provides a description of the cascade of
structural reorganizations coupling the NTDs to the gating
machinery, several questions remain open that suggest future
experimental directions. For example, it is yet unclear whether
in NR1/NR2A receptors the NTDs assemble as heterodimers
as do the ABDs, or alternatively as homodimers. We favor the
heterodimeric arrangement because it maintains the overallNeuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc. 89
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Mechanism of NMDA Receptor Allosteric InhibitionFigure 8. Proposed Model for Allosteric Modulation of NR1/NR2A Receptors
Shown are two subunits forming a functional dimeric unit. An intact NMDA receptor is believed to assemble as a dimer of dimers. For additional details concerning
the model, see Discussion.quaternary arrangement seen at the level of the ABDs (Furukawa
et al., 2005). One then must assume that, in a NR1/NR2A heter-
odimer unit, occupancy of a single NR2A NTD high-affinity zinc-
binding site is sufficient to trigger the conformational changes
required for inhibition. The NR1-NTD, presumably unliganded,
could close with NR2A in a concerted transition, remain in an
open conformation, or be constitutively closed. The fact that tri-
heteromeric NMDA receptors containing a single NR2A subunit
(NR1/NR2A/NR2B or NR1/NR2A/NR2C receptors) retain a high
sensitivity to zinc (but show a decreased maximal level of inhibi-
tion; Hatton and Paoletti, 2005) demonstrates that the binding
energy resulting from occupancy of a single NTD zinc-binding
site in the tetramer is sufficient to shift the equilibrium toward
an increased proportion of inactive receptors.
Another question that remains to be solved is why a saturating
zinc concentration does not fully inhibit NR1/NR2A NMDA re-
ceptors. According to Low et al. (2000), it is because zinc does
not lead to the saturation of the proton binding site. But then,
why does it not? It could be that only a fraction of receptors
with bound zinc have the NTD closed. In other words, zinc bind-
ing may not obligatorily lead to NTD closure, but just shifts the
equilibrium between NTD-open and NTD-closed conformations
toward the NTD-closed conformation (equilibrium between
states 1 and 3; Figure 8). Another possibility is that closure of
the NTD affects the ABD dimer conformation of only a fraction
of receptors. Uncoupling between NTD closure and ABD dimer
separation could be due to structural rearrangements of the
linker region between the NTD and the ABD. The incompleteness
of zinc inhibition would then reflect a competition between two
interfaces, the NTD/ABD intrasubunit interface and the ABD/
ABD intersubunit interface (assuming that disruption of the latter
is required for receptor inhibition) (equilibrium between states 2
and 3; Figure 8). Whatever the mechanism, it is interesting to
note that the incompleteness of zinc inhibition contrasts with
the almost complete extent of desensitization at AMPARs
upon dimer interface disruption (Sun et al., 2002). The mechan-
ical constraints that the NTDs exert on the ABDs may signifi-
cantly differ between the two receptor types. Our observation
that the NR2A-NTD deletion acts synergistically with an ABD
dimer interface mutation on proton sensitivity argues that in90 Neuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc.NMDARs the NR2A-NTD, at least in its open conformation,
may help stabilize the ABD dimer.
Our findings that mutations that increase zinc sensitivity also
increase proton sensitivity agree with the proposal of Low et al.
(2000) that high-affinity zinc inhibition of NR1/NR2A receptors
proceeds through an enhancement of tonic proton inhibition.
The observed 2-fold increase in the speed of MTSES modifi-
cation (Figure 7) is consistent with the observation that satura-
tion of the high-affinity zinc site causes a 0.7 pH unit alkaline
shift of the proton inhibition curve of NR1/NR2A receptors
(Low et al., 2000). At pH 7.3, a 0.7 unit increase in pH sensitivity
would approximately double the fraction of receptors inhibited
by protons (from 30% to 60% of the total receptor population),
which in our model are the receptors that are amenable to
MTSES modification. Moreover, our observation that NR1/
NR2A receptor mutations that disrupt the ABD dimer interface
strongly enhance proton sensitivity provides the important
mechanistic insight that proton inhibition involves separation
of the ABDs. Remarkably, in AMPARs, external acidification
has been shown to enhance desensitization, whereas adding
cyclothiazide, a compound that stabilizes the ABD dimer as-
sembly (Sun et al., 2002), strongly reduces pH sensitivity (Ihle
and Patneau, 2000; Lei et al., 2001). Thus we propose that
breaking the ABD dimer interface is a general mechanism un-
derlying proton modulation of the iGluRs. Whether ABD separa-
tion is required for proton to access its binding site or proton
binding occurs prior ABD separation remains an open question.
The exact location of the proton binding site also remains to be
determined. Based on mutagenesis experiments similar to
ours, Low et al. (2003) have suggested that this site is closely
associated to the transmembrane segments. However, our re-
sults suggest that protons could as well bind at the ABD dimer
interface.
In conclusion, by determining how distal N-terminal domains
communicate in intact NR1/NR2A receptors with the agonist-
binding and gating machinery, our work reveals the molecular
mechanisms by which two naturally occurring modulators of
NMDARs, the H+ and Zn2+ ions, control receptor activity. To-
gether with previous studies on AMPA and kainate receptors,
our results establish that the ligand-binding core dimer is central
Neuron
Mechanism of NMDA Receptor Allosteric Inhibitionin regulating channel activity in the entire iGluR family. Confor-
mational changes at subunit-subunit interfaces are thus critical
events for iGluR function, an idea that is now emerging as a gen-
eral theme in the large family of multimeric neurotransmitter
receptors (Sine and Engel, 2006).
EXPERIMENTAL PROCEDURES
Molecular Biology
The pcDNA3-based expression plasmids for NR1-1a (named NR1 herein) and
NR2A (all rat clones), the mutagenesis strategy, and sequencing have been
described previously (Rachline et al., 2005).
Electrophysiology
Recombinant NMDA receptors were expressed in Xenopus laevi oocytes after
coinjection of cDNAs (at 10 ng/ml; nuclear injection) coding for the various rat
NR1 and NR2A subunits (ratio 1:1). Oocytes were prepared, injected, voltage-
clamped, and superfused as described previously (Paoletti et al., 1995, 1997).
For all experiments, except for those aimed at measuring the pH sensitivity
(see below), the standard external solution contained (in mM) 100 NaCl,
0.3 BaCl2, and 5 HEPES. The pH was adjusted to 7.3 with KOH.
For free zinc concentrations in the 1 nM to 1 mM range, tricine (10 mM) was
used to buffer zinc (Paoletti et al., 1997), and the following relationship was
used to calculate the free zinc concentrations: [Zn]free = [Zn]added/200 (Fayya-
zuddin et al., 2000). In the control ‘‘0’’ added zinc solution, the heavy metal
chelator DTPA (10 mM) was present in addition to tricine. For the zinc concen-
tration-response curves of the mutant receptors displaying a very high zinc
sensitivity (Figures 2 and 3), zinc was not buffered with tricine but with ADA
(1 mM), and the following equation was used to calculate free zinc concentra-
tions ([Zn]free = [Zn]added/17000; Fayyazuddin et al., 2000). For the pH sensitiv-
ity experiments, an enriched HEPES external solution was used to insure
proper pH buffering. This solution contained (in mM) 60 NaCl, 2.5 KCl, and
40 HEPES. pH was first adjusted to 10.3 with NaOH. More acidic solutions
were then obtained by decreasing pH with concentrated HCl. This procedure
was chosen because it maintains Na+ concentration at a constant value,
irrespective of the pH. To chelate trace amounts of contaminant zinc, DTPA
(10 mM) was added in all the solutions used for pH experiments.
NMDA currents were induced by simultaneous application of saturating con-
centrations of L-glutamate and glycine (agonists). These concentrations were
set at 100 mM each for wt receptors. However, because, at NR1/NR2A recep-
tors, both Zn IC50 and maximal inhibition depend on the concentration of gluta-
mate used to activate the receptors (with stronger inhibition with increased
glutamate concentrations; Zheng et al., 2001; Erreger and Traynelis, 2005),
special care was taken to estimate, for each mutant receptor, the appropriate
glutamate concentration required to maximally activate the receptors. For
NR1-L777A/NR2Awt and NR1wt/NR2A-L780A receptors, which display the
strongest shifts in zinc sensitivity, full agonist dose-response curves were per-
formed, revealing agonist sensitivity close to that of wt receptors (Figure S4).
Accordingly, 100 mM glutamate (together with 100 mM glycine) was used with
these receptors. For all other mutants, currents elicited by 100 mM and 1 mM
agonists were initially compared. If these currents differed by less than 15%
(as observed with wt receptors), glutamate and glycine were used at 100 mM
each. This was the case for most of the mutants described in the present study.
For mutant receptors displaying a larger difference (NR1wt/NR2A-I514A,
NR1wt/NR2A-I514D, NR1-CC/NR2A-CC), full agonist concentration-response
curves were performed (Figures S5 and S6) and, in the following zinc/pH exper-
iments, glutamate and glycine concentrations were adjusted to provide maxi-
mal or nearly maximal activation of the receptors (1 mM glutamate and glycine
for NR1-CC/NR2A-CC, 100 mM glycine + 1 mM glutamate for NR1wt/NR2A-
I514A, 100 mM glycine + 10 mM glutamate for NR1wt/NR2A-I514D).
When performing full pH concentration-response curves, at very alkaline
pH values, agonist concentrations were adjusted to compensate for the loss
of protonation of the a-amine moiety (pKa 9.7 for both L-glutamate and
glycine). Thus, at pH 9.3, 9.8, and 10.3, glutamate and glycine concentrations
were increased by 1.4-fold, 2.1-fold, and 5-fold, respectively. At all other pH
values, agonist concentrations were kept identical to those used at pH 7.3.Currents were measured at a holding potential of 60 mV, and experiments
were done at room temperature. Error bars represent the standard deviations
of the mean relative currents.
Redox Treatments of Receptors with Engineered Disulphide Bonds
Because NR1-CC/NR2A-CC receptors exhibit lower agonist affinities com-
pared to wt receptors (Furukawa et al., 2005, and Figure S6), agonist concen-
trations had to be increased from 100 mM (wt receptors) to 1 mM when study-
ing these receptors in order to be at saturating concentrations. This was also
the case for NR1wt/NR2A-CC receptors. To promote disulfide bridge cleav-
age, oocytes were incubated with the reducing agent DTE (5 mM) in a Barth
solution containing (in mM) 88 NaCl, 1 KCl, 0.33 Ca(NO3)2, 0.41 CaCl2, 0.82
MgSO4, 2.4 NaHCO3, and 10 HEPES supplemented with gentamycin (50 mg/
mL) and the NMDAR antagonist D-APV (50 mM) to prevent NMDAR-induced
cell toxicity. pH was adjusted to 8.0. To induce the formation of disulfide
bonds, oocytes were incubated with the oxidizing agent DTNB (0.5 mM) in
the same Barth solution supplemented with gentamycin, D-APV, and the
heavy-metal chelator DTPA (10 mM).
Immunoblotting
Xenopus oocytes were prepared and injected as for the electrophysiological
experiments. After 2–5 days, expression level for NMDA receptors was
checked using two-electrode voltage-clamp, and only oocytes that showed
NMDA currents >300 nA were subsequently used. Oocytes were first treated
with 0.5 mM DTNB for 5 min. They were then homogenized in a buffer
(10 ml/cell) containing 20 mM Tris-HCl (pH 8.0), 50 mM NaCl, 1/100 volume of
mammalian protease inhibitor cocktail (Sigma), and 1 mM N-ethylmaleimide.
After centrifugation (12,200 g for 10 min at 4C), the pellet was then solubilized
in the same buffer complemented with 1% b-D-dodecyl-maltoside (Anatrace).
Sample amounts equivalent to two oocytes were loaded on 8% gels (SDS-
PAGE) either in presence or absence of 100 mM DTE. Gels were incubated
10 min in 1 mM DTE before transfer on PVDF membranes. PVDF membranes
were blocked with fat-free milk (5% in TBS-Tween buffer) and incubated
overnight (4C) with 1/2000 dilution of mouse anti-NR1 antibody (amino acids
660–811, Chemicon) followed by 1/5000 HRP-conjugated goat anti-mouse
secondary antibody and revealed with SuperSignal West Pico Kit (Pierce).
Data Analysis
Data were collected and analyzed using Clampex 7.0 and Clampfit 9.2 (Axon
Instruments, Foster City, CA). Data were fitted using KaleidaGraph 4.0 (Syn-
ergy Software, Reading, PA). For zinc concentration-response curves, the ex-
perimental data points were fitted with the following Hill equation: IZn/IControl =
1  Inhibmax/(1 + (IC50/[Zn])nH), where IZn/IControl is the mean relative current,
[Zn] is the concentration of free zinc, nH is the Hill coefficient, Inhibmax is the
maximal zinc inhibition, and IC50 is the concentration of zinc producing 50%
of the maximal inhibition. IC50, Inhibmax, and nH were fitted as free parameters.
When performing pH experiments, we observed that changes in pH of the
extracellular solution leads to small (a few mV) but significant changes in the
potential of the bath reference electrode, an effect that results in small shifts
of the reversal potential of NMDA responses. To correct for these effects,
the measured NMDA current values were multiplied by the following factor:
0.97 at pH 6.3, 0.98 at pH 6.8, 1.03 at pH 7.8, 1.05 at pH 8.3, 1.07 at pH 8.8,
1.08 at pH 9.3, 1.09 at pH 9.8 and 10.3. To generate pH concentration-re-
sponse curves, a two-step procedure was used. For each cell, the experimen-
tal data points were first fitted using the following Hill equation: IpH/IControl =
b/(1 + 10^(nH (pHIC50  pH))), where IpH/IControl is the relative current (control
current is obtained at pH 7.3), b is the maximum potentiation obtained at
alkaline pH, pHIC50 is the pH producing 50% of inhibition, and nH is the Hill co-
efficient. pHIC50, nH, and bwere fitted as free parameters. For each cell, all data
points were then divided by b to have a maximum relative current normalized
to 1. Resulting values obtained for each individual cell and for each pH were
then averaged, and the mean data points were then fitted with the same Hill
equation as above but with b fixed to 1.0.
To calculate the DG of maximal zinc inhibition (DGZn), we assumed that, at
the plateau of the zinc-concentration response curve (i.e., at saturating zinc
concentrations), the agonist-bound receptors are in equilibrium between two
states, a zinc-bound inactive state (RZn) and a zinc-bound active stateNeuron 57, 80–93, January 10, 2008 ª2008 Elsevier Inc. 91
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Mechanism of NMDA Receptor Allosteric Inhibition(RZn*). Thus, the equilibrium constant KZn between these two states is given by
KZn = [RZn*]/[RZn] = (1  Inhibmax)/Inhibmax (with Inhibmax being the maximal
inhibition produced by zinc; see above) and the corresponding Gibbs free en-
ergy (DGZn) is defined as:DGZn =RT Ln(KZn) =RT Ln(10) log((1 Inhibmax)/
Inhibmax), with R being the gas constant and T the absolute temperature. As an
approximation, we used DGZn (kcal.mol
1) = 1.4 log((1  Inhibmax)/
Inhibmax) at room temperature. For each mutant receptor (mut), we then calcu-
lated the differenceDDGZn(mut) =DGZn(mut)DGZn(wt), whereDGZn(wt) is
theDG of maximal zinc inhibition for wt receptors expressed in the same batch
of oocytes as the studied mutant. We used this procedure to circumvent some
variability seen in the maximal level of zinc inhibition at wt NR1/NR2A receptors
(maximum inhibition 0.77–0.83 range). To quantify proton inhibition, we used
the equilibrium constant KH between the protonated (inactive) and deproto-
nated (active) state of the agonist-bound receptor to calculate the correspond-
ing free energy: DGpH = RT Ln(KH) = RT Ln(10) pHIC50. At room temperature
and at pH 7.3, we used DGpH (kcal.mol
1) = 1.4 pHIC50. For consistency with
the analysis of the maximal zinc inhibition, the difference DDGpH(mut) =
DGpH(mut)  DGpH(wt) was then calculated for each mutant receptor. Of
note, KH accounts for a binding equilibrium, whereas KZn accounts for an equi-
librium between two zinc-bound states and thus does not involve any binding
step.
Chemicals
HEPES, L-glutamate, glycine, DTPA (diethylenetriamine-pentaacetic acid), tri-
cine (N-tris(hydroxymethyl)methylglycine), ADA (N-[2-Acetamido]-2-iminodi-
acetic acid), DTE (dithioerythritol) and DTNB (5,50-dithio-bis(2-nitrobenzoı¨c
acid)) and NEM (N-ethylmaleimide) were obtained from Sigma (Saint-Louis,
MO, USA), D-APV (D-(-)-2-Amino-5-phosphonopentanoic acid) from Ascent
Scientific (Weston-Super-Mare, UK), gentamycin from GIBCO (Invitrogen,
Rockville, MD, USA) and sodium (2-sulfonatoethyl)methane thiosulfonate
(MTSES) from Toronto Research Chemicals (North York, On., Canada). L-glu-
tamate and glycine stock solutions (100 mM to 1 M) were prepared in bidistilled
water. DTNB was prepared as a stock solution (50 mM) in an HEPES solution
(500 mM, pH 8.0), whereas DTE was freshly prepared directly from powder.
MTSES was prepared as 200 mM stock solutions in bidistilled water, aliquoted
in small volumes (200 ml), and immediately frozen at 20C; aliquots were
thawed just before use and replaced every 30 min. Zinc was added as chloride
salts (ZnCl2, ACS reagent quality, Sigma) by dilution from 100 mM stock solu-
tions prepared in 102 N HCl.
3D Structure Illustrations
Figures from the crystal structure of the NR1/NR2A ABD heterodimer (pdb co-
ordinates 2A5T; Furukawa et al., 2005) were prepared with PyMOL (DeLano,
2002).
Supplemental Data
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/57/1/80/DC1/.
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